Guest guest Posted April 4, 2008 Report Share Posted April 4, 2008 http://www.thanhniennews.com/healthy/?catid=8 & newsid=15395 Vietnam orders ban after UK-made children vaccine proves deadly Serious symptoms in a child as Priorix using complications The Vietnamese health ministry has ordered a nationwide ban on Priorix, a vaccine for children imported from the UK, after one child died and five others are in critical condition following inoculation. Assistant Professor Dr Trinh Quan Huan, deputy minister of health, said his ministry had asked the national vaccine analysis institute to analyze the serum which is used against measles, mumps, and rubella. The six victims are from Ho Chi Minh City's District 5. The worst affected is Ng.Thi.B, 13 months, who was admitted to the city's Pediatrics Hospital No 1 Wednesday in medical shock and with breathing difficulty. She had swelling and sores at the injection area and her temperature had shot up to 40oC (104oF). She died the same day. B's relatives said that half an hour after the vaccination, the injected arm swelled, followed by the chest. Ng.M.Q, also 13 months, was hospitalized with the same symptoms plus diarrhea and convulsions. However, the child is out of danger and doctors are now purifying his blood. The doctors said the two patients had complications caused by Priorix which affected their hearts, brains, and livers. Doctor Le Truong, director of the district health center, said the district had been sent a batch of 109 Priorix doses, 76 of which had been used. " Never before have there been any complications from children's vaccination like this one, " a veteran doctor said. Priorix is produced by the UK's GlaxoKline and distributed by Zuellig Pharma. Reported by T.T., L.C. – Translated by Hoang Bao Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.